All In MedTech

Device Trial Radar · NCT04798768

Effectiveness of the EMPOWER™ Modular Pacing System and EMBLEM™ Subcutaneous ICD to Communicate Antitachycardia Pacing

Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingResults posted on the registry

Status

Active, not recruiting

Enrollment

297

Actual

Start

Jul 20, 2021

Primary completion

May 6, 2024

Study completion Dec 31, 2030

Sponsor

Lead sponsor
Boston Scientific CorporationPublic (BSX)
Sponsor type
Industry
First posted
Mar 15, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The MODULAR ATP Clinical Study is designed to demonstrate safety, performance, and effectiveness of the Modular Cardiac Rhythm Management (mCRM) Therapy System.

Conditions

  • Tachycardia, Ventricular
  • Arrhythmia, Ventricular

Interventions

  • mCRM Therapy SystemDevice

    Communication testing between S-ICD and LCP in 4 body postures as well as required electrical testing.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety Endpoint 1: Percentage of Subjects Without Major EMPOWER MPS System- or Procedure-Related Complications Through 6 MonthsTime frame: Implant through 6 Months Post-Implant

3 more outcomes with a free account

Locations

38 sites in 9 countries. Site status is shown where the registry gives one.

  • Banner University Medical Center Phoenix

    Phoenix, Arizona

37 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.